Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyoko Hida

Showing results (51-60 of 107) with videos related to

Pageof 11
Sort By:
Plos One|November 22, 2013
Hypoxia-induced reactive oxygen species cause chromosomal abnormalities in endothelial cells in the tumor microenvironmentMiyako Kondoh, Noritaka Ohga, Kosuke Akiyama, et al.
Cancers|June 2, 2021
The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma PathogenesisGeorge N Tzanakakis, Eirini-Maria Giatagana, Aikaterini Berdiaki, et al.
Oncology Reports|April 17, 2013
Expression of parathyroid hormone-related protein confers malignant potential to mucoepidermoid carcinomaKyosuke Nagamine, Tetsuya Kitamura, Aya Yanagawa-Matsuda, et al.
Cancer Medicine|December 4, 2024
Targeting Tumor Endothelial Cells by EGCG Using Specific Liposome Delivery System Inhibits Vascular Inflammation and ThrombosisZi Jia, Nako Maishi, Hideki Takekawa, et al.
Oncology Letters|January 27, 2017
ALDH1 and podoplanin expression patterns predict the risk of malignant transformation in oral leukoplakiaUmma Habiba, Kyoko Hida, Tetsuya Kitamura, et al.
International Journal of Cancer|March 9, 2011
Cyclooxygenase-2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cellsChikara Muraki, Noritaka Ohga, Yasuhiro Hida, et al.
Thoracic Cancer|March 12, 2021
Biglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancerHirofumi Morimoto, Yasuhiro Hida, Nako Maishi, et al.
Breast Cancer Research : BCR|May 10, 2021
Inhibition of stromal biglycan promotes normalization of the tumor microenvironment and enhances chemotherapeutic efficacyLi Cong, Nako Maishi, Dorcas A Annan, et al.
Oncotarget|May 20, 2017
ROS enhance angiogenic properties via regulation of NRF2 in tumor endothelial cellsTakayuki Hojo, Nako Maishi, Alam Mohammad Towfik, et al.
Journal of Dental Sciences|October 6, 2023
Significant association of Yamamoto-Kohama classification and pathological depth of invasion with cervical lymph node metastasis in early-stage tongue squamous cell carcinoma (Stage I/II)Wataru Kakuguchi, Yuichi Ashikaga, Aya Yanagawa-Matsuda, et al.
Pageof 11

Showing results (51-60 of 107) with videos related to

Sort By:
Pageof 11
Plos One|November 22, 2013
Hypoxia-induced reactive oxygen species cause chromosomal abnormalities in endothelial cells in the tumor microenvironmentMiyako Kondoh, Noritaka Ohga, Kosuke Akiyama, et al.
Cancers|June 2, 2021
The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma PathogenesisGeorge N Tzanakakis, Eirini-Maria Giatagana, Aikaterini Berdiaki, et al.
Oncology Reports|April 17, 2013
Expression of parathyroid hormone-related protein confers malignant potential to mucoepidermoid carcinomaKyosuke Nagamine, Tetsuya Kitamura, Aya Yanagawa-Matsuda, et al.
Cancer Medicine|December 4, 2024
Targeting Tumor Endothelial Cells by EGCG Using Specific Liposome Delivery System Inhibits Vascular Inflammation and ThrombosisZi Jia, Nako Maishi, Hideki Takekawa, et al.
Oncology Letters|January 27, 2017
ALDH1 and podoplanin expression patterns predict the risk of malignant transformation in oral leukoplakiaUmma Habiba, Kyoko Hida, Tetsuya Kitamura, et al.
International Journal of Cancer|March 9, 2011
Cyclooxygenase-2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cellsChikara Muraki, Noritaka Ohga, Yasuhiro Hida, et al.
Thoracic Cancer|March 12, 2021
Biglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancerHirofumi Morimoto, Yasuhiro Hida, Nako Maishi, et al.
Breast Cancer Research : BCR|May 10, 2021
Inhibition of stromal biglycan promotes normalization of the tumor microenvironment and enhances chemotherapeutic efficacyLi Cong, Nako Maishi, Dorcas A Annan, et al.
Oncotarget|May 20, 2017
ROS enhance angiogenic properties via regulation of NRF2 in tumor endothelial cellsTakayuki Hojo, Nako Maishi, Alam Mohammad Towfik, et al.
Journal of Dental Sciences|October 6, 2023
Significant association of Yamamoto-Kohama classification and pathological depth of invasion with cervical lymph node metastasis in early-stage tongue squamous cell carcinoma (Stage I/II)Wataru Kakuguchi, Yuichi Ashikaga, Aya Yanagawa-Matsuda, et al.
Pageof 11